William F. C. Rigby

Tofacitinib for Psoriatic Arthritis in Patients with an Inadequate Response to TNF Inhibitors

Dafna D. Gladman, William F. C. Rigby, Valderílio Feijó Azevedo et al. · New England Journal of Medicine · 2017 · 508 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

MK2‐induced tristetraprolin:14‐3‐3 complexes prevent stress granule association and ARE‐mRNA decay

Georg Stoecklin, Tiffany Stubbs, Nancy Kedersha et al. · The EMBO Journal · 2004 · 506 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +15

Upadacitinib as monotherapy in patients with active rheumatoid arthritis and inadequate response to methotrexate (SELECT-MONOTHERAPY): a randomised, placebo-controlled, double-blind phase 3 study

Josef S Smolen, Aileen L. Pangan, Paul Emery et al. · The Lancet · 2019 · 378 citations

Medicine, Pharmacology, Pharmacotherapy +10

Glyceraldehyde-3-phosphate Dehydrogenase Selectively Binds AU-rich RNA in the NAD+-binding Region (Rossmann Fold)

Eszter Nagy, William F. C. Rigby · Journal of Biological Chemistry · 1995 · 362 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +12

Efficacy and safety of different doses and retreatment of rituximab: a randomised, placebo-controlled trial in patients who are biological naïve with active rheumatoid arthritis and an inadequate response to methotrexate (Study Evaluating Rituximab's Efficacy in MTX iNadequate rEsponders (SERENE))

P. Emery, Atul Deodhar, William F. C. Rigby et al. · Annals of the Rheumatic Diseases · 2010 · 347 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14